Journal article

FGF10 Triggers de novo Alveologenesis in a Bronchopulmonary Dysplasia Model: Impact on Resident Mesenchymal Niche Cells


Authors listTaghizadeh, Sara; Chao, Cho-Ming; Guenther, Stefan; Glaser, Lea; Gersmann, Luisa; Michel, Gabriela; Kraut, Simone; Goth, Kerstin; Koepke, Janine; Heiner, Monika; Vazquez-Armendariz, Ana Ivonne; Herold, Susanne; Samakovlis, Christos; Weissmann, Norbert; Ricci, Francesca; Aquila, Giorgio; Boyer, Laurent; Ehrhardt, Harald; Minoo, Parviz; Bellusci, Saverio; Rivetti, Stefano

Publication year2022

Pages605-617

JournalStem Cells

Volume number40

Issue number6

ISSN1066-5099

eISSN1549-4918

Open access statusHybrid

DOI Linkhttps://doi.org/10.1093/stmcls/sxac025

PublisherOxford University Press


Abstract
Bronchopulmonary dysplasia (BPD) is a neonatal lung disease developing in premature babies characterized by arrested alveologenesis and associated with decreased Fibroblast growth factor 10 (FGF10) expression. One-week hyperoxia (HYX) exposure of newborn mice leads to a permanent arrest in alveologenesis. To test the role of Fgf10 signaling to promote de novo alveologenesis following hyperoxia, we used transgenic mice allowing inducible expression of Fgf10 and recombinant FGF10 (rFGF10) protein delivered intraperitoneally. We carried out morphometry analysis, and IF on day 45. Alveolospheres assays were performed co-culturing AT2s from normoxia (NOX) with FACS-isolated Sca1(Pos) resident mesenchymal cells (rMC) from animals exposed to NOX, HYX-PBS, or HYX-FGF10. scRNAseq between rMC-Sca1(Pos) isolated from NOX and HYX-PBS was also carried out. Transgenic overexpression of Fgf10 and rFGF10 administration rescued the alveologenesis defects following HYX. Alveolosphere assays indicate that the activity of rMC-Sca1(Pos) is negatively impacted by HYX and partially rescued by rFGF10 treatment. Analysis by IF demonstrates a significant impact of rFGF10 on the activity of resident mesenchymal cells. scRNAseq results identified clusters expressing Fgf10, Fgf7, Pdgfra, and Axin2, which could represent the rMC niche cells for the AT2 stem cells. In conclusion, we demonstrate that rFGF10 administration is able to induce de novo alveologenesis in a BPD mouse model and identified subpopulations of rMC-Sca1(Pos) niche cells potentially representing its cellular target.



Citation Styles

Harvard Citation styleTaghizadeh, S., Chao, C., Guenther, S., Glaser, L., Gersmann, L., Michel, G., et al. (2022) FGF10 Triggers de novo Alveologenesis in a Bronchopulmonary Dysplasia Model: Impact on Resident Mesenchymal Niche Cells, Stem Cells, 40(6), pp. 605-617. https://doi.org/10.1093/stmcls/sxac025

APA Citation styleTaghizadeh, S., Chao, C., Guenther, S., Glaser, L., Gersmann, L., Michel, G., Kraut, S., Goth, K., Koepke, J., Heiner, M., Vazquez-Armendariz, A., Herold, S., Samakovlis, C., Weissmann, N., Ricci, F., Aquila, G., Boyer, L., Ehrhardt, H., Minoo, P., ...Rivetti, S. (2022). FGF10 Triggers de novo Alveologenesis in a Bronchopulmonary Dysplasia Model: Impact on Resident Mesenchymal Niche Cells. Stem Cells. 40(6), 605-617. https://doi.org/10.1093/stmcls/sxac025



Keywords


alveologenesisBRANCHING MORPHOGENESISFGF-10GROWTH-FACTOR 10MOUSE LUNGrFGF10rMC-Sca1(Pos)scRNASeq

Last updated on 2025-10-06 at 11:39